Founded in 2019, our journey has been one of strategic evolution: From a regional pharmaceutical intermediate trader to a globally recognized partner for integrated cross-border supply and technical solutions. With over six years of concentrated expertise in the pharmaceutical and fine chemical sectors, we are dedicated to the mission of "Empowering Pharmaceutical Innovation. " By proactively navigating industry shifts and capitalizing on emerging opportunities, we have established a reputation for reliability and built solid, enduring partnerships across the globe.
Shanghai pemichem Co. Ltd., established in 2019, is a globally oriented innovation-driven enterprise dedicated to advancing ife sciences throuohintegrated solutions. As a certified national high-tech enterprise, we speciaize in end-to-end services encompassing pharmaceutical active ingredients(apis), advanced intermediates, bioactive compounds, peptide therapeutics, veterinary pharmaceuticals, and speciaty chemical reagents, while pioneeringbreakthrouohs in cosmetic functional ingredients and novel health materials
In Virto Diagnostic Test Kit, Medical Sodium Hyaluronate Gel, Hyaluronic Acid Dermal Filler, Hemostatic Products
Country/Region:
Zhejiang, China
R&D Capacity:
ODM Service
Sample Service:
Sample Available
Company Profile:
Founded in 2002, Singclean Medical has been dedicated to the innovation of absorbable biomaterials, and now has 20 years of expertise in the industry of absorbable biomaterials and ranks among the top 3 Chinese Manufacturer and one of the world's leading innovators in this industry.
Fine Chemicals, Pharmaceutical Intermediates, Chemical Raw Materials, OLED Materials., Lithium-Based New Energy Materials.
Country/Region:
Shanghai, China
Sample Service:
Sample Available
Company Profile:
Shanghai Likai Chemical Technology Co., Ltd. Was established in September 2020, headquartered in Songjiang District, Shanghai. With a registered capital of 5 million CNY, the company holds hazardous chemical operation licenses and import/export rights, focusing on fine chemicals, new energy materials, and pharmaceutical intermediates.